Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.1 | uM | 8 | 156.25 | 28.44 | 93.00 | 89.50 | 1.0391 | 1.0469 |
| BT-20 | Lapatinib | 0.031623 | uM | 8 | 156.25 | 28.44 | 125.00 | 89.50 | 1.3966 | 1.4476 |
| BT-20 | 17-AAG | 0.031623 | uM | 8 | 156.25 | 28.44 | 44.00 | 89.50 | 0.4916 | 0.3020 |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 76.00 | 89.50 | 0.8492 | 0.8118 | |
| BT-20 | 0 | uM | 8 | 156.25 | 28.44 | 82.00 | 89.50 | 0.9162 | 0.8969 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 162.00 | 202.25 | 0.8010 | 0.4192 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 162.00 | 202.25 | 0.8010 | 0.4192 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 197.00 | 202.25 | 0.9740 | 0.9203 | |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 312.50 | 129.17 | 245.00 | 202.25 | 1.2114 | 1.6901 |
| BT-20 | 17-AAG | 0.001 | uM | 8 | 312.50 | 129.17 | 251.00 | 202.25 | 1.2410 | 1.7926 |
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 312.50 | 129.17 | 257.00 | 202.25 | 1.2707 | 1.8964 |
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 312.50 | 129.17 | 309.00 | 202.25 | 1.5278 | 2.8510 |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 312.50 | 129.17 | 439.00 | 202.25 | 2.1706 | 5.6270 |
| BT-20 | Lapatinib | 0.1 | uM | 8 | 312.50 | 129.17 | 375.00 | 202.25 | 1.8541 | 4.1943 |
| BT-20 | Lapatinib | 0.0016596 | uM | 8 | 312.50 | 129.17 | 400.00 | 202.25 | 1.9778 | 4.7393 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 320.00 | 202.25 | 1.5822 | 3.0649 | |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 312.50 | 129.17 | 126.00 | 202.25 | 0.6230 | -0.0376 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 312.50 | 129.17 | 409.00 | 202.25 | 2.0222 | 4.9401 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 312.50 | 129.17 | 306.00 | 202.25 | 1.5130 | 2.7933 |
| BT-20 | Linsitinib | 0.31623 | uM | 8 | 312.50 | 129.17 | 294.00 | 202.25 | 1.4536 | 2.5658 |
| BT-20 | Lapatinib | 0.01 | uM | 8 | 312.50 | 129.17 | 270.00 | 202.25 | 1.3350 | 2.1260 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 312.50 | 129.17 | 290.00 | 202.25 | 1.4339 | 2.4911 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 312.50 | 129.17 | 309.00 | 202.25 | 1.5278 | 2.8510 |
| BT-20 | Erlotinib | 1 | uM | 8 | 312.50 | 129.17 | 275.00 | 202.25 | 1.3597 | 2.2160 |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 312.50 | 129.17 | 231.00 | 202.25 | 1.1422 | 1.4562 |